Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant nonsyndromic deafness that is characterized postlingual onset in the second decade of life with flat progressive hearing loss and has material basis in mutation in the MIRN96 gene on chromosome 7q32.
Features include sometimes findings: Tinnitus. 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 4 | Progressive sensorineural hearing impairment, Inner ear hearing loss (sensorineural hearing impairment), Tinnitus |
MIR96 encodes microRNA 96. Highest expression in Adipose Subcutaneous (0.0 TPM) and Adipose Visceral Omentum (0.0 TPM).
Autosomal dominant nonsyndromic hearing loss 50 is associated with mutations in the MIR96 gene on chromosome 7.
MIR96 is classified as a druggable target with score 0.0.
Genetic testing for MIR96 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for autosomal dominant nonsyndromic hearing loss 50.
12 publications have been identified in PubMed for autosomal dominant nonsyndromic hearing loss 50. Kisho has analyzed 8 by research type. Research spans Basic Science / Preclinical (63%), Case Report / Case Series (25%), and Review / Meta-Analysis (13%).
Ranganathan R (2025). [PMID: 40213817](https://pubmed.ncbi.nlm.nih.gov/40213817/). *Development*. [Basic Science / Preclinical]
Soleimani F (2025). [PMID: 41307816](https://pubmed.ncbi.nlm.nih.gov/41307816/). *Biochem Genet*. [Case Report / Case Series]
Zhang Y (2025). [PMID: 41015553](https://pubmed.ncbi.nlm.nih.gov/41015553/). *Zhong Nan Da Xue Xue Bao Yi Xue Ban*. [Basic Science / Preclinical]
Sekiguchi R (2024). [PMID: 39388000](https://pubmed.ncbi.nlm.nih.gov/39388000/). *JA Clin Rep*. [Case Report / Case Series]
Zhang L (2024). [PMID: 39556694](https://pubmed.ncbi.nlm.nih.gov/39556694/). *Adv Sci (Weinh)*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:32 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Yu S (2024). [PMID: 39720982](https://pubmed.ncbi.nlm.nih.gov/39720982/). *Mol Genet Genomics*. [Basic Science / Preclinical]
Zhu W (2024). [PMID: 38985856](https://pubmed.ncbi.nlm.nih.gov/38985856/). *Sci Transl Med*. [Basic Science / Preclinical]
Reichenberger EJ (2024). [PMID: 39165910](https://pubmed.ncbi.nlm.nih.gov/39165910/). *JBMR Plus*. [Basic Science / Preclinical]